NO914481L - PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS - Google Patents
PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLSInfo
- Publication number
- NO914481L NO914481L NO91914481A NO914481A NO914481L NO 914481 L NO914481 L NO 914481L NO 91914481 A NO91914481 A NO 91914481A NO 914481 A NO914481 A NO 914481A NO 914481 L NO914481 L NO 914481L
- Authority
- NO
- Norway
- Prior art keywords
- mean
- azols
- substituted
- procedure
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/68—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
Azoler med formel. der X, Y og Z står for N eller CR, der Rblant annet kan bety hydrogen, klor, metoksy, benzyloksy. L kan blant annet bety -CE-, A betyr en aromatisk eller heterocykllsk rest og T en binding eller en toverdig rest, Ri kan blant annet bety (CR3-C5 )-alkyl og E kan blant annet bety følgende formel. Det blir beskrevet en fremgangsmåte for fremstilling, og midler som inneholder disse forbindelsene og deres anvendelse som helnlngsmiddel.Azoles with formula. where X, Y and Z stand for N or CR, where R may mean hydrogen, chlorine, methoxy, benzyloxy, among others. L can mean -CE-, A means an aromatic or heterocyclic radical and T a bond or a divalent radical, R 1 can mean (CR 3 -C 5) -alkyl and E can mean the following formula. A process for its preparation and compositions containing these compounds and their use as a healing agent are described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4036645A DE4036645A1 (en) | 1990-11-16 | 1990-11-16 | SUBSTITUTED AZOLE, METHOD FOR THE PRODUCTION THEREOF, THE AGENT, AND THEIR USE THEREOF |
Publications (2)
Publication Number | Publication Date |
---|---|
NO914481D0 NO914481D0 (en) | 1991-11-15 |
NO914481L true NO914481L (en) | 1992-05-18 |
Family
ID=6418438
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO91914481A NO914481L (en) | 1990-11-16 | 1991-11-15 | PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0485929A1 (en) |
JP (1) | JPH04283569A (en) |
KR (1) | KR920009802A (en) |
CN (1) | CN1061410A (en) |
AU (1) | AU8785591A (en) |
BR (1) | BR9104948A (en) |
CA (1) | CA2055636A1 (en) |
CS (1) | CS347091A3 (en) |
DE (1) | DE4036645A1 (en) |
FI (1) | FI915381A (en) |
HU (1) | HUT59673A (en) |
IE (1) | IE913991A1 (en) |
IL (1) | IL100058A0 (en) |
MX (1) | MX9102098A (en) |
NO (1) | NO914481L (en) |
PT (1) | PT99521A (en) |
ZA (1) | ZA919059B (en) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4036706A1 (en) * | 1990-11-17 | 1992-05-21 | Hoechst Ag | METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA |
US5616599A (en) * | 1991-02-21 | 1997-04-01 | Sankyo Company, Limited | Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use |
DE4200954A1 (en) * | 1991-04-26 | 1992-10-29 | Bayer Ag | New heterocycle-substd. phenylacetic acid derivs. - are angiotensin II antagonists for treating arterial hypertonia, atherosclerosis, coronary insufficiency, ischaemic cerebral disorders, respiratory disorders, etc. |
CZ283315B6 (en) * | 1992-12-17 | 1998-02-18 | Sankyo Company Limited | Biphenyl derivatives, process of their preparation and pharmaceutical preparation containing thereof |
US5300668A (en) * | 1993-03-10 | 1994-04-05 | Pfizer Inc. | Certain esters of 1-(4-X-methylphenyl)cyclopent-3-ene-1-carboxylic acid, wherein X is a trialkylsilyloxy, bromo or hydroxy group, as intermediates |
DE19645313A1 (en) | 1996-11-04 | 1998-05-07 | Basf Ag | Substituted 3-benzylpyrazoles |
SE9903028D0 (en) | 1999-08-27 | 1999-08-27 | Astra Ab | New use |
PE20070182A1 (en) | 2005-07-29 | 2007-03-06 | Wyeth Corp | CYANOPYRROL-PHENYL AMIDE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS |
PE20070404A1 (en) | 2005-07-29 | 2007-05-10 | Wyeth Corp | COMPOUNDS DERIVED FROM CYANOPYRROL-SULFONAMIDE AS MODULATORS OF THE PROGESTERONE RECEPTOR |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EP2970384A1 (en) | 2013-03-15 | 2016-01-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
AU2014274812B2 (en) | 2013-06-05 | 2018-09-27 | Bausch Health Ireland Limited | Ultra-pure agonists of guanylate cyclase C, method of making and using same |
WO2023274257A1 (en) * | 2021-07-01 | 2023-01-05 | 诸葛国琴 | Imidazole compound, and intermediate and application thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1329614C (en) * | 1987-05-02 | 1994-05-17 | Rainer Buerstinghaus | N-substituted azoles |
CA1338238C (en) * | 1988-01-07 | 1996-04-09 | David John Carini | Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids |
-
1990
- 1990-11-16 DE DE4036645A patent/DE4036645A1/en not_active Withdrawn
-
1991
- 1991-11-11 EP EP91119186A patent/EP0485929A1/en not_active Withdrawn
- 1991-11-14 IL IL100058A patent/IL100058A0/en unknown
- 1991-11-14 FI FI915381A patent/FI915381A/en unknown
- 1991-11-14 BR BR919104948A patent/BR9104948A/en unknown
- 1991-11-15 CN CN91110736A patent/CN1061410A/en active Pending
- 1991-11-15 MX MX9102098A patent/MX9102098A/en unknown
- 1991-11-15 PT PT99521A patent/PT99521A/en not_active Application Discontinuation
- 1991-11-15 JP JP3326662A patent/JPH04283569A/en active Pending
- 1991-11-15 AU AU87855/91A patent/AU8785591A/en not_active Abandoned
- 1991-11-15 NO NO91914481A patent/NO914481L/en unknown
- 1991-11-15 KR KR1019910020341A patent/KR920009802A/en not_active Application Discontinuation
- 1991-11-15 CA CA002055636A patent/CA2055636A1/en not_active Abandoned
- 1991-11-15 ZA ZA919059A patent/ZA919059B/en unknown
- 1991-11-15 IE IE399191A patent/IE913991A1/en not_active Application Discontinuation
- 1991-11-15 HU HU913583A patent/HUT59673A/en unknown
- 1991-11-15 CS CS913470A patent/CS347091A3/en unknown
Also Published As
Publication number | Publication date |
---|---|
CS347091A3 (en) | 1992-06-17 |
DE4036645A1 (en) | 1992-05-21 |
EP0485929A1 (en) | 1992-05-20 |
PT99521A (en) | 1992-09-30 |
HU913583D0 (en) | 1992-01-28 |
NO914481D0 (en) | 1991-11-15 |
HUT59673A (en) | 1992-06-29 |
ZA919059B (en) | 1992-07-29 |
KR920009802A (en) | 1992-06-25 |
CA2055636A1 (en) | 1992-05-17 |
IE913991A1 (en) | 1992-05-20 |
FI915381A (en) | 1992-05-17 |
CN1061410A (en) | 1992-05-27 |
FI915381A0 (en) | 1991-11-14 |
BR9104948A (en) | 1992-06-23 |
IL100058A0 (en) | 1992-08-18 |
JPH04283569A (en) | 1992-10-08 |
AU8785591A (en) | 1992-05-21 |
MX9102098A (en) | 1992-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO914481L (en) | PROCEDURE FOR MANUFACTURING AND USING SUBSTITUTED AZOLS | |
DK0503162T3 (en) | Asole derivatives, processes for their preparation and their use | |
NO20025821L (en) | 2-aminocarbonyl-9H-purine | |
ATE98290T1 (en) | DIFLUOROMETHYL COMPOUNDS. | |
CA2274464A1 (en) | Ketobenzamides as calpain inhibitors | |
CA2017934A1 (en) | Nitrogen-containing titanocenes, and the use thereof | |
CA2195243A1 (en) | Triazole compounds and the use thereof | |
NO971625L (en) | Novel peptides with immunomodulatory effects | |
CA2080249A1 (en) | Preparation of substituted piperidines | |
MY131693A (en) | Arylacetic acid derivatives | |
CA2298461A1 (en) | Heterocyclic substituted 4-benzoyl-pyrazole as herbicides | |
ZA982137B (en) | Cycloalkylalkanecarboxamides and their preparation and use. | |
NO884523L (en) | IODATED POLYMERS, THE PROCEDURE FOR THEIR PREPARATION AND THEIR USE AS CONTRACTING AGENTS. | |
CA2188796A1 (en) | Heterocyclylbenzonitriles | |
BG98238A (en) | Substituted benzothiazole derivatives, methods for their preparation and their application as herbicides | |
NO943765L (en) | Aryloksybenzen-herbicidmidler | |
ATE149159T1 (en) | HETEROARYLMETHYLBENZOLE AROMATIC INHIBITORS | |
NO950665L (en) | New polyiodized compounds, methods of their preparation and contrast agents containing them | |
BR9916154A (en) | 1 3, 5 replaced triazines | |
NO965267D0 (en) | Glucuronyl compounds, and process for preparing the same | |
ATE135010T1 (en) | NEW BETA-GALACTOSIDASE SUBSTRATES FOR CEDIA | |
IL95608A0 (en) | 1-methoxypyrimidinyl-n-nitro-phenyl-1h,1,2,4-triazole-3-sulphonamide derivatives and herbicidal compositions containing the same | |
IL67400A0 (en) | 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them | |
TW328085B (en) | Novel amino acid derivatives for the treatment or prevention of multi-drug resistance | |
EP0392680A3 (en) | Aromatic compounds |